Nobuaki Ito

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 362 citations

Medicine, Pharmacology, Psychiatry +15

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 340 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

A Novel Mutation in Fibroblast Growth Factor 23 Gene as a Cause of Tumoral Calcinosis

Kaori Araya, Seiji Fukumoto, Rebecca Backenroth et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 221 citations · Full text

Medicine, Endocrinology, Pathobiology +16

Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli

Nobuaki Ito, Asiri R. Wijenayaka, Matthew Prideaux et al. · Molecular and Cellular Endocrinology · 2014 · 174 citations

Medicine, Oral Biology, Orthopaedic Surgery +12

Hyperostosis–Hyperphosphatemia Syndrome: A Congenital Disorder of <i>O</i>-Glycosylation Associated With Augmented Processing of Fibroblast Growth Factor 23

Yaacov Frishberg, Nobuaki Ito, Choni Rinat et al. · Journal of Bone and Mineral Research · 2006 · 164 citations

Medicine, Endocrinology, Molecular Medicine +17